1. Home
  2. SPPL vs PASG Comparison

SPPL vs PASG Comparison

Compare SPPL & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SPPL

SIMPPLE LTD.

HOLD

Current Price

$2.51

Market Cap

23.7M

Sector

N/A

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$5.00

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPPL
PASG
Founded
2016
2017
Country
Singapore
United States
Employees
N/A
27
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
26.0M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
SPPL
PASG
Price
$2.51
$5.00
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
1.3M
122.4K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.28
52 Week High
$7.00
$20.00

Technical Indicators

Market Signals
Indicator
SPPL
PASG
Relative Strength Index (RSI) 64.13 33.13
Support Level $2.51 N/A
Resistance Level $3.63 $7.92
Average True Range (ATR) 0.14 0.84
MACD 0.07 -0.42
Stochastic Oscillator 95.45 2.38

Price Performance

Historical Comparison
SPPL
PASG

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software (Facilities management software). The majority of its revenue is generated from the Robots segment. The company has expanded its operations into Australia /New Zealand and may also enter or expand in other geographic markets such as Canada, Hong Kong, Japan, the Middle East, the United Kingdom, Europe and the United States.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: